Commentary
par
Clarke, Hance et al
Date de publication
2019
Géographie
Canada
Langue de la ressource
Both
Texte disponible en version intégrale
Oui
Open Access / OK to Reproduce
Non
Évalué par des pairs
No
Constatations/points à retenir
The evidence recommending nonopioid medications to be superior to opioid medications for chronic noncancer pain can (similarly to the evidence for opioid superiority) be criticized for not having adequate long-term follow-up, for small sample sizes, and for a lack of functional outcome data. However well meaning they are, the 2017 Canadian opioid prescribing guidelines were introduced to a health care system ill equipped to care for patients with chronic pain.
Mots clés
Policy/Regulatory
About prescribers
Chronic pain